BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
BillionToOne (NASDAQ: BLLN) will report first quarter 2026 financial results after market close on May 6, 2026.
Rhea-AI Summary
BillionToOne (NASDAQ: BLLN) will report first quarter 2026 financial results after market close on May 6, 2026. The company will host a conference call at 1:30pm PT / 4:30pm ET that day to discuss results and provide a live webcast.
Analysts must register before the 1:30pm PT start. A live and archived webcast will be available on BillionToOne's Events page at https://investors.billiontoone.com/.
Positive
- None.
Negative
- None.
Details
News Market Reaction – BLLN
On Apr 15, the day this news came out, BLLN closed 2.63% below the previous close.
Data tracked by StockTitan Argus for the Apr 15 session.
Key Figures
- Quarter end date
- March 31, 2026
- First quarter 2026 period end
- Earnings release date
- May 6, 2026
- Planned Q1 2026 results release after market close
- Conference call time PT
- 1:30 PM Pacific Time
- Q1 2026 results conference call start
- Conference call time ET
- 4:30 PM Eastern Time
- Q1 2026 results conference call start
Previous Earnings date Reports
-
Announced Q4/FY2025 results date and conference call/webcast details.
-
Set Q3 2025 results release date and investor call registration details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for the first quarter ended March 31, 2026 after the market close on Wednesday, May 6, 2026. BillionToOne will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day.
Analysts planning to participate in the conference call should register here before the 1:30pm Pacific Time / 4:30pm Eastern Time start. A live and archived webcast for interested listeners will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/.
About BillionToOne
Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.
Investor Contact
ir@billiontoone.com
Media Contact
billiontoone@moxiegrouppr.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.